Turkish Journal of Biology
Volume 35

Number 5

Article 10

1-1-2011

Preliminary studies on antiinflammatory, antipyretic, and
antidiarrhoeal properties of Evolvulus alsinoides
U.M.DHANA LEKSHMI
P.NEELAKANTA REDDY

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
LEKSHMI, U.M.DHANA and REDDY, P.NEELAKANTA (2011) "Preliminary studies on antiinflammatory,
antipyretic, and antidiarrhoeal properties of Evolvulus alsinoides," Turkish Journal of Biology: Vol. 35: No.
5, Article 10. https://doi.org/10.3906/biy-0904-19
Available at: https://journals.tubitak.gov.tr/biology/vol35/iss5/10

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turk J Biol
35 (2011) 611-618
© TÜBİTAK
doi:10.3906/biy-0904-19

Preliminary studies on antiinflammatory, antipyretic, and
antidiarrhoeal properties of Evolvulus alsinoides

U. M. Dhana LEKSHMI, P. Neelakanta REDDY
Bio Organic Chemistry Laboratory, Central Leather Research Institute, (Council of Scientific and Industrial Research)
Adyar, Chennai -600020 - INDIA

Received: 27.04.2009

Abstract: e ethanolic extract of the whole plant of Evolvulus alsinoides L. (Convolvulaceae) was investigated for
antiinflammatory, antipyretic and antidiarrhoeal properties in female albino rats. Preliminary phytochemical studies
were carried out to confirm the presence of active chemical constituents in the plant extract, and the result showed a
positive report for the presence of flavonoids, alkaloids and cardiac glycosides. e pharmacological result showed that
the ethanolic extract at a dose of 250 mg/kg body weight and 500 mg/kg body weight caused a significant (P < 0.05)
inhibition of the carrageenan-induced rat paw oedema and a significant (P < 0.05) reduction of hyperpyrexia induced
by Brewer’s yeast in rats. e extract also elicited marked antidiarrhoeal activity against castor oil-induced diarrhoea at
a dose of 500 mg/kg. is study has proved scientifically the ancient claim that the whole plant of Evolvulus alsinoides has
antiinflammatory, antipyretic and antidiarrhoeal activities.
Key words: Evolvulus alsinoides, antiinflammatory, antipyretic, antidiarrhoeal, rats, carrageenan, brewer’s yeast, castor
oil

Evolvulus alsinoides’un antiinflamatuar, antipiretik ve
antidiyare özellikleri üzerine ön çalışmalar
Özet: Evolvulus alsinoides L. (Convolvulaceae) tüm bitkisinin etanolik özütü, dişi albino sıçanlarda antiinflamatuar,
antipiretik ve antidiyare özellikleri bakımından araştırıldı. Bitki özütündeki aktif kimyasal bileşenlerinin varlığını
doğrulamak için ön fitokimyasal çalışmalar yapıldı ve sonuç flavonoidlerin, alkaloidlerin ve kardiyak glikozitlerin
varlığına dair olumlu bir rapor gösterdi. Farmakolojik sonuç, vücut ağırlığının 250 mg/kg ve 500 mg/kg dozundaki
etanolik özütün sıçanlarda karajenle teşvik edilen sıçan ayak ödemi inhibisyonuna önemli ölçüde (P < 0,05) ve bira
mayasıyla teşvik edilen hiperpireksinin azalmasına önemli ölçüde (P < 0,05) neden olduğunu gösterdi. Ayrıca özüt, 500
mg/kg dozda hint yağıyla teşvik edilen diyareye karşı antidiyarel aktiviteyi belirgin şekilde ortaya çıkardı. Bu çalışma;
antiinflamatuar, antipiretik ve antidiyare aktiviteleri bakımından tüm Evolvulus alsinoides bitkisi hakkındaki atasal iddiayı
bilimsel olarak kanıtlamıştır.
Anahtar sözcükler: Evolvulus alsinoides, antiinflamatuar, antipiretik, antidiyare, sıçanlar, karajenan, bira mayası, hint yağı
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Introduction
Evolvulus alsinoides L. (Convolvulaceae),
commonly known as ‘shankhpuspi’ in India, Africa,
and the Philippines, is an important medicinal plant
employed for different ailments in India traditionally.
It grows in open and grassy places throughout almost
all of India and subtropical countries of the world
(1,2). The oldest reports found of the use of E.
alsinoides are from India and surrounding regions.
The herb was used to treat dysentery (3).
Mohammedan physicians used the plant as a general
tonic to strengthen the brain and memory and to treat
fever (4). E. alsinoides was used to treat bowel
problems and to promote conception (5,6). The entire
plant was considered astringent and useful for treating
haemorrhages, and there are a variety of other
medical applications, including use as an adaptogenic,
antiphlogistic, antipyretic, antiseptic, aphrodisiac,
febrifuge, stomachic, tonic, and vermifuge, in the
treatment of asthma, bronchitis, scrofula, syphilis, or
in “controlling night emissions,” and to promote
wound healing (7-10). It appears that E. alsinoides has
some phytochemicals that are effective against the
maladies for which people use them. The isolation of
evolvin, kaempferol-3-O-β-D glucopyranoside,
coumarin etc., from E. alsinoides has been previously
reported (11).
Carrageenan-induced inflammation is useful in
detecting orally active antiinflammatory agents (12).
Oedema formation due to carrageenan in the rat paw
is a biphasic event. The initial phase is attributed to
the release of histamine and serotonin. The second
phase of oedema is due to the release of
prostaglandins, protease and lysosomes (13,14). There
is evidence that compounds inhibiting carrageenaninduced oedema are also effective against cyclo
oxygenase enzymes (15). Brewer’s yeast-induced
pyrexia has been used as a screening tool for
antipyretic agents in rodents (16,17).
Castor oil causes diarrhoea due to its active
metabolite, ricinoleic acid (18,19), which stimulates
peristaltic activity in the small intestine, leading to
changes in the electrolyte permeability of the
intestinal mucosa. Its action also stimulates the release
of endogenous prostaglandins. Non-steroidal
antiinflammatory drugs (NSAIDs) are commonly
used to treat inflammation and pyrexia, and opioid
612

derivatives are used to treat diarrhoea, but they are
toxic and not always free from adverse effects (20,21).
Hence a natural agent with less or no toxicity is
necessary. A range of medicinal plants with
antiinflammatory, antipyretic, and antidiarrhoeal
properties is widely used by traditional healers. In
view of E. alsinoides’ importance in traditional
medicinal systems, no substantial phytochemical and
pharmacological works have been reported based on
the antiinflammatory, antipyretic, and antidiarrhoeal
properties. Preclinical (in vivo and in vitro)
investigations have demonstrated only the
antiamnesic,
antistress,
antimicrobial,
and
gastroprotective activity of E. alsinoides (22,23).
Further clinical studies are needed to prove
scientifically E. alsinoides’ antiinflammatory,
antipyretic, and antidiarrhoeal properties.
In the present research, preliminary studies in
female albino rats were carried out to determine the
effects of ethanolic extract of Evolvulus alsinoides on
carrageenan-induced inflammation, brewer’s yeastinduced pyrexia, and castor oil-induced diarrhoea by
a single experiment in each case to prove the
mentioned activities.
Materials and methods
Materials
Fresh whole plants of E. alsinoides were collected
in the Tambaram area of Chennai, Tamil Nadu
(INDIA), and identified by Prof Dr. Jayaraman, Plant
Anatomy and Research Centre, Tambaram, Chennai,
India, where its voucher specimen (PARC/2008/152)
was deposited.
Carrageenan (Sigma, US),
Indomethacin (Indocid R, Merck Sharp –Dohme),
Brewer’s yeast (Hi-media, Mumbai),
Paracetamol (Cipla Ltd, Nalagarh),
Castor oil (sd-fine chemicals, Mumbai),
Diphenoxylate (Pfizer US pharmaceuticals group).
Preparation of plant extract
The plant materials were shade dried, powdered
(800 g), and subsequently subjected to the extraction
process. The solvent was removed at 30 °C using a
rotary evaporator. The yield of ethanolic extract was
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23 g (2.87%). Dilutions of the extract were made in
2% gum acacia for antiinflammatory, antipyretic
studies and in tween 80 for antidiarrhoeal studies.
Animals
The Wistar female albino rats (180-200 g) used for
this study were procured from King Institute Guindy,
Chennai, India, and housed in the Institutional
animal house under standard environmental
conditions (23 ± 1 °C, 55 ± 5% humidity and 12 h/12
h light/dark cycle) and maintained with free access to
standard diet (Hindustan Lever, Bangalore, India) and
water ad libitum. The 72 animals were divided into 3
groups, each group containing 24 animals, and they
were further divided into 4 sub-groups (n = 6 per subgroup) and housed in polypropylene cages. The
protocol of animal study was approved by the
Institutional Animal Ethics Committee (IAEC
03/003/08).
Phytochemical analysis
Preliminary phytochemical analysis
The preliminary phytochemical properties of the
extract were tested for alkaloids with Mayers and
Dragendroffs reagents, saponins glycosides with the

ability to produce suds, cardiac glycosides with FeCl2
and H2SO4, flavonoids with the use of Mg and HCl,
anthraquinones with Borntragers reaction, terpenoids
by the Liebermann-Burchard method and the use of
H2SO4, tannins with 1% gelatin and 10% NaCl
solutions (24).
Pharmacological activities
Antiinflammatory activity
Carrageenan-induced oedema test:
Pedal inflammation in female Wistar albino rats
weighing 180-200 g was produced in group 1 (25). A
dose of 0.1 mL 1% carrageenan (1 g in 100 mL of gum
acacia) was injected into the right hind foot of each
rat under the sub plantar region. The control group
of sub-group I received 2.8 mL/kg body weight of 2%
gum acacia, and the indomethacin group received
indomethacin in 2% gum acacia orally at a dose of 20
mg/kg body weight. The third sub-group of group I
were treated with a dose of 250 mg extract/kg body
weight, and the fourth sub-group of group I received
500 mg extract/kg body weight, 1 h prior to the
administration of the phlogistic agent. The volume of
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the hind paw was measured before injection of the
phlogistic agent and then at hourly intervals for a
period of 4 h after injection of phlogistic agent using
a mercury displacement plethysmograph. A
significant reduction in paw volume compared to
control group was considered to be an
antiinflammatory response (26,27).
Percentage inhibition =

Vc – Vt

× 100

Vc
Vc = paw volume for control;
Vt = paw volume for test.
Antipyretic activity
Yeast-induced hyper pyrexia in rats
Rectal temperature was recorded with a digital
thermometer. Hyperpyrexia was induced in rats by
injecting 20% (20 g of dried yeast in 100 mL of 2%
gum acacia in normal saline) suspension of dried
yeast at a volume of 20 mL/kg body weight
subcutaneously (16). The animals were then fasted for
the 18 h duration of the experiment, and water was
provided ad libitum. In all animals of sub-groups of
group 2, temperatures were taken 18 h after the yeast
injection to determine the pyretic response to yeast,
and rats which showed a rise in temperature of at least
0.5 °C to 1 °C were taken into the experiment. Group
2, the control group (sub-group I), received 2% gum
acacia, the paracetamol group (sub-group II) received
paracetamol (33 mg/kg of body weight in 2% gum
acacia), and sub-groups III and IV received orally 250
mg/kg and 500 mg/kg body weight doses of the
extract, respectively. The rectal temperature was
recorded at 1, 2, 3, and 4 h after administration of the
extract and paracetamol. Percentage reduction in
rectal temperature was calculated by the following
formula (28,29):
% reduction =

B – Cn

× 100.

B–A
A- Normal temperature.
B- Rectal temperature at 18 h after yeast
administration.
Cn- rectal temperature after drug administration.
614

Antidiarrhoeal activity
Castor oil-induced diarrhoea
All rats of group 3 were fasted for 18 h. Castor oil
at a dose of 1 mL per animal orally was given to all
sub-groups of group 3 for the induction of diarrhoea.
After 30 min, the first sub group (control) of group 3
received 1 mL of 0.5% (v/v) tween 80. The second
sub-group received diphenoxylate (50 mg/kg body
weight) (30). The third and fourth sub-groups were
treated with extract (250 mg/kg and 500 mg/kg body
weight doses, respectively). Animals of all sub-groups
of group 3 were placed separately in individual cages
lined with filter paper (31). The filter papers were
changed every hour and the severity of diarrhoea was
assessed hourly for 6 h. The total number of faeces
were recorded with in a period of 6 h and compared
with the control group. The total number of
diarrhoeal faeces of the control group was considered
100%. The results were expressed as percentage
inhibition of diarrhoea (21).
Statistical analysis
The statistical analysis of data was analysed by
analysis of variance (ANOVA) followed by Student ttest for comparison between experiment and control
groups. The statistical package used was SPSS 15.0
software. Values were expressed as mean ± S.E.M. and
those values with P < 0.05 were considered significant.
Results and discussion
Antiinflammatory effect
Carrageenan-induced rat paw oedema was
markedly inhibited by oral pre-treatment with the
extract (250 mg/kg and 500 mg/kg body weight doses)
and indomethacin (20 mg/kg body weight dose)
(Table 1). In the acute inflammation model, a dose of
250 mg/kg body weight of the extract showed
significant inhibition (P < 0.05) at 3 and 4 h, whereas
indomethacin and the extract (500 mg/kg body
weight) exhibited significant inhibition at 2, 3, and 4
h.
Antipyretic studies
Table 2 shows that 18 h after yeast injection,
hyperthermia was recorded and continued
throughout the test. The plant extract produced a
reduction in hyper pyrexia induced by yeast injection
in rats, with activity being pronounced within 90 min
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Table 1. Effects of the ethanol extract of Evolvulus alsinoides whole plant on carrageenan-induced paw oedema in rats.
Mean paw volume (in mL)

Group 1

I Control 2% gum acacia
II Indomethacin
III E. alsinoides extract
IV E. alsinoides extract

Oral
dose/body
weight

Before
carrageenan

After carrageenan
1h

2h

3h

4h

2.8 mL/kg
20 mg/kg
250 mg/kg
500 mg/kg

1.67 ± 0.12
1.84 ± 0.06
1.9 ± 0.07
1.93 ± 0.08

2.27 ± 0.6
2.12 ± 0.07
2.25 ± 0.04
2.18 ± 0.02

3.28 ± 0.09
1.98 ± 0.05 *
2.94 ± 0.05
2.00 ± 0.02*

4.23 ± 0.04
1.87 ± 0.06*
2.23 ± 0.02*
1.99 ± 0.06*

4.67 ± 0.04
1.85 ± 0.07*
1.95 ± 0.05*
1.9 ± 0.05*

All values are expressed in mean ± SEM (n = 6)
*P < 0.05 significant compared to control

after administration of the extract. Also, within 2 h of
administration of the extract, the plant extract was as
effective as paracetamol in reducing hyperthermia (P
< 0.05).
Antidiarrhoeal studies
The rats of sub-group I of group 3 that did not
receive the plant extract showed typical diarrhoea signs
such as watery and frequent defecation. The extract at
a dose of 250 mg/kg did not show any significant
reduction in castor oil-induced diarrhoea, but showed
significant reduction (P < 0.001) at a dose of 500 mg/kg
body weight. Both doses of the extract significantly

decreased (P < 0.05) diarrhoea as compared to the
control group (Table 3), but not very significantly when
compared with the diphenoxylate group.
Phytochemical studies
Phytochemical studies showed that the applied
extract was positive for alkaloids, cardiac glycosides,
and flavonoids, and negative for saponins and
terpenoids.
In the present study, the pharmacological activities
of the ethanol extract of E. alsinoides were studied.
The extract was found to significantly inhibit

Table 2. Effects of the ethanol extract of E. alsinoides on yeast-induced pyrexia in rats.
Rectal temperature (°C)
Group 2

Dose/kg
body weight

Rectal temperature after drug administration in
°C (percentage inhibition in rectal temperature)

Normal
(A)

After yeast
+ 18 h (B)

+1h
(C1)

+2h
(C2)

+3h
(C3)

+4h
(C4)

Control 2% gum
acacia (I)

2.8 mL/
rat

37.4 ± 0.08

38.8 ± 0.23

38.7 ± 0.1
(---)

38.6 ± 0.13
(---)

38.7 ± 0.08
(---)

38.7 ± 0.08
(---)

Paracetamol (II)

33 mg

37.5 ± 0.13

38.6 ± 0.12

37.6 ± 0.11*
(90)

37.6 ± 0.09*
(90)

37.6 ± 0.11*
(90)

37.5 ± 0.13*
(100)

Extract (III)

250 mg

37.31 ± 0.08

38.7 ± 0.05

38.3 ± 0.16
(28.77)

37.7 ± 0.07*
(71.94)

37.6 ± 0.07*
(79.31)

37.5 ± 0.04*
(86.33)

Extract (IV)

500 mg

37.4 ± 0.06

38.7 ± 0.08

38.1 ± 0.08*
(46.15)

37.6 ± 0.05*
(84.61)

37.6 ± 0.05*
(84.61)

37.5 ± 0.05*
(92.30)

Effects of the ethanol extract of E. alsinoides on yeast-induced pyrexia in rats.
All values are expressed in mean ± SEM (n = 6), percentage reduction in rectal temperature is given within parentheses
*P < 0.05 significant compared to control
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Table 3. Effects of the ethanol extract of E. alsinoides on castor oil-induced diarrhoea in rats.

Group 3

Dose

Total number
of faeces

Total number of
diarrhoeal faeces

Inhibition
(%)

Total weight
of faeces

Inhibition
(%)

Control (I)

Castor oil 1 mL + 0.5%
tween 80

25.2 ± 1.49

18 ± 0.71

0.00

9.76 ± 0.35

0.00

Diphenoxylate (II)

50 mg/kg + castor
oil (1 mL)

7.8 ± 0.37***

5.2 ± 1.30***

71.72

1.76 ± 0.57***

81.97

Extract (III)

250 mg/kg + castor
oil (1 mL)

18.65 ± 0.98*

6.3 ± 0.84

65

4.78 ± 1.28*

51.29

Extract (IV)

500 mg/kg + castor
oil (1 mL)

18 ± 0.71*

5.9 ± 1.30***

67.23

2.98 ± 0.58**

69.46

Values are expressed as mean ± SEM (n = 6)
P < 0.01**, P < 0.001*** when compared with control.

carrageenan-induced rat paw oedema, a test which
has a significant predictive value for antiinflammatory
agents acting by inhibiting the mediators of acute
inflammation (32). The antiinflammatory effect of the
crude extract of the plant at a 500 mg/kg dose in the
second hour after carrageenan injection strongly
suggests its NSAID-like activity (Table 1). Similarly,
the standard drug indomethacin produced a
significant antiedematous effect, which was in
accordance with previous reports indicating that
NSAIDs show marked inhibition of carrageenaninduced oedema in rats (33,34). The extract showed
antipyretic activity in rats made hyperthermic by yeast
injection. The active constituents may exhibit both
central and peripheral actions because pyrexia and
inflammation are central and peripheral processes,
respectively. E. alsinoides extract produced significant
antipyretic activity at a dose of 500 mg/kg (Table 2).
Since antipyretic activity is commonly mentioned as
characteristics of drugs or compounds which have an
inhibitory effect on prostaglandin (PG) biosynthesis,
yeast-induced hyperpyrexia in a rat model was
employed (35). In general, NSAIDs produce their
antipyretic action through inhibition of prostaglandin
synthetase within the hypothalamus (36,37).
Although there is no direct evidence that the extract
of E. alsinoides interferes with PG synthesis in
hypothalamus, it can only be supported by a related
study in which E. alsinoides extract was found to have
antistress activity, immunomodulatory and
616

gastroprotective activity, and so the action of extract
particularly on PG synthesis requires further
confirmation (11,22). It appears that antipyretic
action of E. alsinoides extract may be related to the
inhibition of PG synthesis in the hypothalamus. Such
reduction of the rectal temperature of the tested
animals by extract appears to be due to the presence
of a single bio-active substance or mixture of
compounds in them. Thus the activities shown by the
crude extract could be a useful factor in its application
in febrifuge. In this study, ethanol extract of E.
alsinoides exhibited a significant antidiarrhoeal
activity (Table 3) when compared with the control
group. The extract of E. alsinoides showed dosedependent effects in controlling the diarrhoea. The
results are similar to those of the standard drug
diphenoxylate with regard to severity of diarrhoea
(38). These findings support the use of E. alsinoides
in various ailments. Therefore, further studies are
needed for the isolation and characterisation of the
active constituents responsible for these activities.
Corresponding author:
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